A Temporary Extension for the Rare Pediatric Disease Priority Review Voucher with a Longer-Term Extension in Sight?
FDA Law Blog
OCTOBER 13, 2024
While the dates have been written in the law, the previous extensions provided a reasonable hope that the program would continue. This bill would extend the designation deadline until September 30, 2029, a five-year extension (and would require yet another GAO report). After all, this is what incentives are for.
64 
Let's personalize your content